159 related articles for article (PubMed ID: 16310700)
21. Scar or recurrent rectal cancer. Positron emission tomography is more helpful for diagnosis than immunoscintigraphy.
Schlag P; Lehner B; Strauss LG; Georgi P; Herfarth C
Arch Surg; 1989 Feb; 124(2):197-200. PubMed ID: 2783844
[TBL] [Abstract][Full Text] [Related]
22. The role of positron emission tomography in the management of recurrent colorectal cancer: a review.
Watson AJ; Lolohea S; Robertson GM; Frizelle FA
Dis Colon Rectum; 2007 Jan; 50(1):102-14. PubMed ID: 17115340
[TBL] [Abstract][Full Text] [Related]
23. Late assessment of local control by PET in patients with distal rectal cancer managed non-operatively after complete tumor regression following neoadjuvant chemoradiation.
Habr-Gama A; Gama-Rodrigues J; Perez RO; Proscurshim I; São Julião GP; Kruglensky D; Kiss D; Ceconello I; Buchpiguel CA
Tech Coloproctol; 2008 Mar; 12(1):74-6. PubMed ID: 18524026
[No Abstract] [Full Text] [Related]
24. PET/CT and histopathologic response to preoperative chemoradiation therapy in locally advanced rectal cancer.
Kristiansen C; Loft A; Berthelsen AK; Graff J; Lindebjerg J; Bisgaard C; Jakobsen A
Dis Colon Rectum; 2008 Jan; 51(1):21-5. PubMed ID: 17975715
[TBL] [Abstract][Full Text] [Related]
25. An audit of fusion CT-PET in the management of colorectal liver metastases.
Khan S; Tan YM; John A; Isaac J; Singhvi S; Guest P; Mirza DF
Eur J Surg Oncol; 2006 Jun; 32(5):564-7. PubMed ID: 16564155
[TBL] [Abstract][Full Text] [Related]
26. Recurrent rectal cancer: how to predict resectability?
Vogl TJ; Pegios W
Front Radiat Ther Oncol; 2004; 38():37-40. PubMed ID: 15458185
[No Abstract] [Full Text] [Related]
27. [Detection of liver metastases and recurrence using PET-CT scan in a patient with rectal cancer].
Jun DW; Choi JH; Park YS
Korean J Gastroenterol; 2006 Aug; 48(2):63-6. PubMed ID: 16929148
[No Abstract] [Full Text] [Related]
28. Value of 18F-fluoro-2-deoxyglucose positron emission tomography in the evaluation of recurrent colorectal cancer.
Hung GU; Shiau YC; Tsai SC; Chao TH; Ho YJ; Kao CH
Anticancer Res; 2001; 21(2B):1375-8. PubMed ID: 11396217
[TBL] [Abstract][Full Text] [Related]
29. In regard to Ciernik et al.: Automated functional image-guided radiation treatment planning for rectal cancer (Int J Radiat Oncol Biol Phys 2005;62:893-900).
Roels S; Haustermans K; Grégoire V; Withers HR
Int J Radiat Oncol Biol Phys; 2006 Apr; 64(5):1611-2; author reply 1612-3. PubMed ID: 16580510
[No Abstract] [Full Text] [Related]
30. Radiological appearances in the pelvis following rectal cancer surgery.
Tan PL; Chan CL; Moore NR
Clin Radiol; 2005 Aug; 60(8):846-55. PubMed ID: 16039920
[TBL] [Abstract][Full Text] [Related]
31. [Determination of therapy management in rectal carcinoma by staging with 18-FDG-PET].
Mirzaei S; Schratter-Sehn AU; Knoll P; Gerber E; Kumpan W; Schiessel R; Raderer M; Köhn H
Chirurg; 2001 Sep; 72(9):1058-61. PubMed ID: 11594277
[TBL] [Abstract][Full Text] [Related]
32. [Localization of a tumor of unknown origin by means of 18-fluorodeoxyglucose positron emission tomography].
Ortega A; Pérez-Castejón MJ; Jiménez-Vicioso A; Expósito R; Domper M; Montz R; Carreras JL
Rev Clin Esp; 2000 Aug; 200(8):457-9. PubMed ID: 11076189
[No Abstract] [Full Text] [Related]
33. Recurrent hepatic epithelioid hemangioendothelioma: detection by FDG PET/CT.
Lin E; Agoff N
Clin Nucl Med; 2007 Dec; 32(12):949-51. PubMed ID: 18030050
[TBL] [Abstract][Full Text] [Related]
34. [Evaluation of positron emission tomography by using F-18-fluorodeoxyglucose in diagnosis of recurrent colorectal cancer].
Kula Z; Szefer J; Zuchora Z; Romanowicz G; Pietrzak T
Pol Merkur Lekarski; 2004; 17 Suppl 1():63-6. PubMed ID: 15603351
[TBL] [Abstract][Full Text] [Related]
35. Fusion image of positron emission tomography and computed tomography for the diagnosis of local recurrence of rectal cancer.
Fukunaga H; Sekimoto M; Ikeda M; Higuchi I; Yasui M; Seshimo I; Takayama O; Yamamoto H; Ohue M; Tatsumi M; Hatazawa J; Ikenaga M; Nishimura T; Monden M
Ann Surg Oncol; 2005 Jul; 12(7):561-9. PubMed ID: 15889211
[TBL] [Abstract][Full Text] [Related]
36. Combined FDG-positron emission tomography and computed tomography for the detection of ovarian cancer recurrence in an inguinal hernia sac.
Díaz-Montes TP; Jacene HA; Wahl RL; Bristow RE
Gynecol Oncol; 2005 Sep; 98(3):510-2. PubMed ID: 15992914
[TBL] [Abstract][Full Text] [Related]
37. Predicting response to chemoradiotherapy in rectal and oesophageal cancer with 18F-FDG: prognostic value and possible role in patient management.
Hindié E; Hennequin C; Moretti JL
Eur J Nucl Med Mol Imaging; 2007 Oct; 34(10):1576-82. PubMed ID: 17579856
[No Abstract] [Full Text] [Related]
38. Role of 2-[18F] fluoro-2-deoxy-D-glucose-positron emission tomography/computed tomography in the post-therapy surveillance of breast cancer.
Chang HT; Hu C; Chiu YL; Peng NJ; Liu RS
PLoS One; 2014; 9(12):e115127. PubMed ID: 25517451
[TBL] [Abstract][Full Text] [Related]
39. Is combined 18F-fluorodeoxyglucose-positron emission tomography/computed tomography superior to positron emission tomography or computed tomography alone for diagnosis, staging and restaging of pancreatic lesions?
Casneuf V; Delrue L; Kelles A; Van Damme N; Van Huysse J; Berrevoet F; De Vos M; Duyck P; Peeters M
Acta Gastroenterol Belg; 2007; 70(4):331-8. PubMed ID: 18330088
[TBL] [Abstract][Full Text] [Related]
40. PET-CT fusion in radiation management of patients with anorectal tumors.
Anderson C; Koshy M; Staley C; Esiashvili N; Ghavidel S; Fowler Z; Fox T; Esteves F; Landry J; Godette K
Int J Radiat Oncol Biol Phys; 2007 Sep; 69(1):155-62. PubMed ID: 17707268
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
